Easton Pharmaceutical Gets NMPA Nod for Generic Version of Merck KGaA’s Concor
Easton Pharmaceutical Co., Ltd (SHA: 688513), based in Chengdu, has announced that it has received...
GQCE testing
Guangzhou and Zhuhai Unveil Measures to Stimulate Biopharmaceutical Industry Growth
In a bid to bolster the biopharmaceutical and health industries, the cities of Guangzhou and...
CDE Seeks Public Feedback on Latest Batch of Generic Drug Reference Preparations
The Center for Drug Evaluation (CDE), a key regulatory body overseeing pharmaceutical evaluations in China,...
NMPA Releases 78th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 78th batch of reference drugs for...
CDE Opens Consultation on 79th Batch of Generic Drug Reference Preparations
The Center for Drug Evaluation (CDE) has issued a call for feedback on the 79th...
China’s NMPA Releases 77th Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has released the 77th batch of reference drugs for...
NMPA Expands Generic Drug Catalog with 74th and 75th Batches for Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 74th and 75th batches of reference...
CDE Requests Feedback on 77th Batch of Chemical Generic Reference Preparations by December 20
The Center for Drug Evaluation (CDE) is currently soliciting feedback on the 77th batch of...
Nanchang Baiji Pharmaceutical’s Budesonide Nasal Spray Approved by China’s NMPA
Nanchang Baiji Pharmaceutical Co. Ltd., a Chinese pharmaceutical company, has received approval from the National...
CDE Releases 76th Batch of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 76th batch of chemical generic reference...
Chongqing Lummy Pharmaceutical’s Generic Ramosetron Passes GQCE in China
China-based Chongqing Lummy Pharmaceutical Co., Ltd (SHE: 300006) has announced that its generic version of...
NMPA Unveils 73rd Batch of Reference Drugs for Generic Quality Consistency
China’s National Medical Products Administration (NMPA) has released the 73rd batch of reference drugs as...
CDE Releases 75th Batch of Generic Reference Preparations with Updated Specifications
The Center for Drug Evaluation (CDE) has announced the release of the 75th batch of...
NMPA Announces Pathway for Developing Generic Drugs Without Reference Preparation
The National Medical Products Administration (NMPA) has issued an announcement regarding the development of generic...
CDE Introduces New Guidelines for Generic Drug Quality and Efficacy Consistency Evaluation
The Center for Drug Evaluation (CDE) has released a new set of Guidelines for “the...
CDE Releases 74th Batch of Generic Reference Preparations with 58 New Specifications
The Center for Drug Evaluation (CDE) has released the 74th batch of chemical generic reference...
China’s CDE Proposes Removal of Ambroxol Inhalation Solution and Four Other Drugs
The Center for Drug Evaluation has issued a notification concerning the Chemical Generic Drug Reference...
CDE Releases 73rd Batch of Chemical Generic Reference Preparations with Updates
The Center for Drug Evaluation (CDE) has released the 73rd batch of chemical generic reference...
NMPA Releases 72nd Batch of Reference Drugs for GQCE
The National Medical Products Administration (NMPA) has released the 72nd batch of reference drugs for...
NMPA Releases 70th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 70th batch of reference drugs for...